BOLERO-4: Phase 2 trial of first-line everolimus (EVE) plus letrozole (LET) in estrogen receptor–positive (ER+), human epidermal growth factor receptor 2–negative (HER2-) advanced breast cancer (BC)
Royce M., Villanueva C., Ozguroglu M., Bachelot T., Azevedo S., Melo Cruz F., ...More
Annals of Oncology, vol.27, 2016 (SCI-Expanded, Scopus)
-
Publication Type:
Article / Article
-
Volume:
27
-
Publication Date:
2016
-
Doi Number:
10.1093/annonc/mdw365.01
-
Journal Name:
Annals of Oncology
-
Journal Indexes:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Istanbul University-Cerrahpasa Affiliated:
No